$AMRN going to “try” and not look today at price swings. I was very confident that Amrn and vascepa are tremendous opportunities for patients (and shareholders). Now I am 99.999% convinced. Regardless of whatever happens today or by Friday’s options expiry, I am holding. More cash coming eom. Will continue to volume average every month. Gl today and I am going to try really really hard not to watch price changes.